Researchers at the Max Planck Institute for Intelligent Systems and their collaborators have made a breakthrough in nanomotors for future applications in medicine by developing the first ever fully biocompatible self-propelling particles that are powered by enzymes that consume biological fuels, such as glucose.
In a study published today in Nanoletters, Max Planck research group leader and ICREA research professor Samuel Sánchez and his collaborators at the University of Tübingen and the MPI for Solid State Research, Germany, describe their fabrication of the world’s first enzyme-powered synthetic nanomotors that overcome the disadvantages of current systems by being both biocompatible and powered by biologically benign fuels.
The new bio-friendly mini motors, which are made from hollow mesoporous silica proven to be harmless to cells and tissues, will be able to be used in biomedical applications, as their self-propulsion is powered by the biocatalytic reactions of three different naturally occurring enzymes: catalase, urease, and glucose oxidase. The enzymatic reactions power the Janus nanoparticles – special types whose surfaces have two or more distinct physical properties – by occurring asymmetrically on only one surface, propelling them in the opposite direction. Not only that, but the researchers based in Tübingen also broke new ground during this study by measuring, for the first time, the propulsion force of nanomotors using optical tweezers, leading to a better understanding of how self-propelled nanoparticles behave.
“To be safe for use in applications in medicine in the body, nanoparticles need to be made out of biocompatible and biodegradable materials, as well as being capable of both autonomous motion using biologically benign fuels and cargo delivery – such as drug delivery – at small scales,” says Samuel, who heads what has been described as ‘one of the leading groups in the field’ of nanomotor research, the Smart Nano-Bio-Devices group, with locations at the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart and at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona. “We’ve tackled all these issues with our new particles. For their architecture, we used a material which offers a high drug-loading capacity owing to its hollow structure; and for propulsion, we based our methods on the quite recent discovery that enzymes by themselves can act as self-propelled nanomotors as well as being anchored to larger artificial objects, such as carbon nanotubes, to provide a propulsion force using catalytic reactions.”
Such biocatalytic reactions triggered by enzymes consume non-toxic ‘fuel’, as they are naturally present in a biological environment.Different enzyme/fuel combinations can also be used, such as catalase and hydrogen peroxide or glucose and glucose oxidase, meaning the method is very versatile with the potential to be extended to further enzymes.
Previous active micro-and nanosystems developed for potential biomedical uses – as carriers of drug molecules to targeted sites, for example – were limited when it came to real applications because their usual methods of propulsion, such as the decomposition of hydrogen peroxide and platinum, were short-lived and harsh; others were simply passive nanosystems, unable to move autonomously. Additionally, these nanomotors are for first time made up of non-metallic components but only made of silica and enzymes, which assures their biocompatibility and potential biodegradation .
The next steps for the researchers will be to explore how to increase the effective driving force and guide their bio-friendly nanomotors by external manipulation methods, such as chemotaxis, magnetic control or ultrasound, leading to directional movement for active drug delivery to specific locations.
The Max Planck Institute for Intelligent Systems with locations in Stuttgart and Tübingen emerged in 2011 from the Max Planck Institute for Metals Research in Stuttgart. In eight departments, scientists conduct research in the fields of materials science, computer science and biology.
Annette Stumpf | Max-Planck-Institut für Intelligente Systeme
Magic number colloidal clusters
13.12.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Record levels of mercury released by thawing permafrost in Canadian Arctic
13.12.2018 | University of Alberta
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences